Early Phase 1 Relapsed/refractory Lymphoma Clinical Trials
2 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
Relapsed/refractory LymphomaRelapsed/Refractory Leukemia
Affiliated Hospital of Nantong University9 enrolled1 locationNCT06756321
Recruiting
Early Phase 1
Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
Relapsed/refractory Lymphoma
Shanghai First Song Biotechnology Co., LTD9 enrolled1 locationNCT06532643